Who is at risk of misusing pharmaceuticals? Overdose in Victoria. But I don t have a drug problem 10/18/2018. Rates of opioid prescribing

Similar documents
REAL TIME MONITORING OF PRESCRIPTION MEDICINES BEING A HEALTHY STATE

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION

Controlled Substance and Wellness Agreement

MEDICATION GUIDE Oxycodone Hydrochloride (ox-ee-co-dohn) (CII) Oral Solution, USP

Opioids Research to Practice

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

National Council on Patient Information and Education

MEDICATION GUIDE Morphine Sulfate (mor-pheen) (CII) Oral Solution

Pharmaceutical Drugs & Real-Time Prescription Monitoring.

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Tablets (CIII)

Trust Board Meeting in Public: Wednesday 13 January 2016 TB

Taking the pain out of prescribing: An opioid primer for the primary care provider

Share the important information in this Medication Guide with members of your household.

MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII)

SUBSTANCE ABUSE IN THE ELDERLY. The Invisible Epidemic

MEDICATION GUIDE Morphine Sulfate (MOR feen SUL fate) (CII) Oral Solution

Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04

Tuscarawas County Health Department. Vivitrol Treatment Consent

How to take your Opioid Pain Medication

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

What is the most important information I should know about Morphine Sulfate Oral Solution?

Opioid rotation or switching may be considered if a patient obtains pain relief with one opioid and is suffering severe adverse effects.

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII)

MEDICATION GUIDE SUBOXONE (Sub OX own) (buprenorphine and naloxone) Sublingual Film for sublingual or buccal administration (CIII)

MEDICATION GUIDE MORPHINE Sulfate Oral Solution (mor-pheen) CII Rx only

Opioids Research to Practice

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine

Opioid Prescribing for Acute Pain

MEDICATION GUIDE CODEINE SULFATE (koh-deen) CII Oral Solution

Real-time prescription monitoring system in Victoria

Pain CONCERN. Medicines for long-term pain. Opioids

Prescription Opioid Addiction

Opioids Research to Practice

Opioids for persistent pain: Information for patients. The British Pain Society's

MEDICATION MANAGEMENT AGREEMENT

Clinical Guidelines and Procedures for the Use of Naltrexone in the Management of Opioid Dependence Abbreviated Version

Opioids Research to Practice

some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment

Position is based Access Health & Community: Hawthorn and Doncaster East Manager, Alcohol and Other Drug Service

You will be prescribed a preparation in the strength of 1mg/1ml. Methadone, like heroin can also cause a physical dependence.

Patient Information Leaflet. Opioid leaflet. Produced By: Chronic Pain Service

Managing presenting problems with benzodiazepines. By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead

Slow Release Opioids. Morphine (Zomorph/MST) Oxycodone (Longtec, Oxycontin) Tapentadol (Palexia) For the Treatment of Pain

Updated: 08/2017 DMMA Approved: 11/2017

OPIOIDS FOR PERSISTENT PAIN: INFORMATION FOR PATIENTS

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment

SCENARIOS IN SUBSTANCE MISUSE. By Dr Gideon Felton Consultant Psychiatrist and Clinical Lead

H NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher.

ROSC & MAT II: Opioid Treatment Services

INFORMED CONSENT FOR OPIOID TREATMENT FOR NON-CANCER/CANCER PAIN Texas Pain and Regenerative Medicine

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE SHARED CARE AGREEMENT

Naloxone in Schools. Training for School Staff

Referral to the Women s Alcohol and Drug Service (WADS) Procedure

Opioid Type Pain Killers

Taking opioid pain medicine safely

Primary Health Networks

Talking with your doctor

Taking Opioids Responsibly for Your Safety and the Safety of Others: Patient Information Guide on Long-term Opioid Therapy for Chronic Pain

Understanding Bipolar Disorder

Buprenorphine Patch (Transtec Patch)

Initial Patient Questionnaire

TEMGESIC Injection Buprenorphine (as hydrochloride)

Updated Activity Work Plan : Drug and Alcohol Treatment NEPEAN BLUE MOUNTAINS PHN

SW OREGON OPIOID SUMMIT. Medication Assisted Recovery for Opioid Use Disorder. Gregory S. Brigham, Ph.D. Adapt / SouthRiver CHC / Compass

A guide to reducing or stopping mental health medication. Notes for prescribers

PAIN RELIEF AFTER SURGERY

Substance Misuse in Older People

Opioids Research to Practice

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

SUBOXONE TREATMENT PROGRAM

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Ms Anne Dowden. Independent Evaluation Consultant Wellington

Acupuncture. Opioid Prescribing: Pitfalls for Occupational Medicine Physicians

Alberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007

Treating Opioid Addiction

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE

Alcohol Use in the Elderly

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION

MEDICATION ASSISTED TREATMENT

SOCI221. Session 11. Crisis and Trauma Issues: Alcohol and other drugs; Eating disorders and Referrals. Department of Social Science

Updated Activity Work Plan : Drug and Alcohol Treatment. Western NSW PHN

University College Hospital

Complexity and Addiction in Older Adults: The Role of the Advanced Practice Nurse. Dr Adam Searby RMIT University, Melbourne, Australia

Pain Management for Adult sickle cell disease patients: Information for patients, relatives and carers

Orexo completes 1,080 patient REZOLV study and reports on improved treatment of opioid dependent patients

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

Addressing Alaska s Opioid Epidemic From Understanding to Action

Guidelines for Community Detoxification using Buprenorphine.

Naloxone Administration Training

HA Corporate Scholarship Program:

Primary Health Networks

What is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration

SUBOXONE Sublingual Tablets Buprenorphine Hydrochloride + Naloxone Hydrochloride Consumer Medicine Information

Consulted With: Post/Committee/Group: Date: John Crome Drug and Alcohol Liaison Emergency Care

Alcohol, drug and related health and wellbeing issues among young people completing an online screen.

Referral to the Women s Alcohol and Drug Service (WADS) Procedure

OPIOID WITHDRAWAL WITH YOUR PATIENTS

Transcription:

But I don t have a drug problem Engaging With Consumers Affected By Medication Misuse How many people reported misusing a medication in the past year? What percentage of people who misuse medication are aged 50 or older? 1 in 2 1 in 8 1 in 10 1 in 20 13% 45% 56% 68% What percentage of people who misuse opioids, report misusing an over-thecounter codeine? 5% 25% 50% 75% Rates of opioid prescribing 2002-2008 SOURCE: Roxburgh et al, 2011 OXYCODONE Fig 1: Rates of PBS Scripts for Opioids in Australia 2010 2015 (Monheit et al, 2016) Overdose in Victoria 2016 2017 Road Toll 291 255 Deaths by OD 492 523 Deaths by OD due to pharmaceuticals 381 (77.4%) 414 (79.2%) Deaths by OD due to Illicit 263 (53.5%) 271 (51.8%) Who is at risk of misusing pharmaceuticals? People who report misusing pharmaceuticals are more likely to be: Unable to participate in the workforce Living in remote/regional areas Experiencing health problems and chronic pain Aboriginal or Torres Strait Islander Older adults (over 55 years) BUT it can happen to anyone Coroner s Court of Victoria, 2016 Coroner s Court of Victoria, 2018, COR 2016 2730 National Drug and Alcohol Research Centre, 2018 Australian Institute of Health & Welfare, 2017 1

Stigma Health Professional I don t see that type of patient It takes the pain away, what s wrong with that? Community Addicts only have themselves to blame All addicts are dangerous They are bums Self-generated It s only medicine. I don t have a drug problem I only use it help me sleep It was given to me by doctor, so it can t be unsafe Analgesics Anxiolytics Stimulants Other Psychiatric Medication Opioid pain killers Paracetamol Anti-inflammatory drugs Sleeping tablets Benzodiazepines Sedatives Ritalin Modafinil Dexamphetamines Anti-depressants Anti-psychotics Mood stabilisers Signs of problematic use Signs of problematic use Psychosocial problems as a result of use Medical/health problems as a result of use Using larger amounts or more often than intended Hiding use from others or lying about medication use Feeling unable to cope without using medication Mood swings, irritability or anger Difficulty cutting down or stopping Withdrawal symptoms when reduced/stopped Needing to take more and more Spending a lot of time/money on medications Relying on the medication to manage sleep/emotions Doctor shopping or pharmacy shopping Signs of withdrawal SafeScript Anxiety Muscle aches Pain Increased tearing Insomnia Runny nose Sweating Yawning Abdominal cramping Diarrhea Dilated pupils Goose bumps Nausea Vomiting Real-time prescription monitoring system commencing 1 st October 2018 (full roll-out across Victoria by 2019 2020) 2

What is the Medication Support and Recovery Service? Medication Support & Recovery Service A new addiction treatment service specialising in helping people who use prescription and over-the-counter medications A unique FREE service in Victoria based in community health, providing specialised pharmaceutical treatment services We support anyone who is dependent on or misusing medications, and their families Clients can access our service regardless of age or postcode Self-referrals are accepted No Medicare Card or Mental Health Treatment Plan or Chronic Disease Management Plan is needed Locations Access Health and Community Hawthorn Doncaster East Link Health and Community Glen Waverley Clayton Carrington Health Box Hill Inspiro Community Health Lilydale Healesville Belgrave Banyule Community Health West Heidelberg Greensborough Epping Our Services Wrap-around approach within primary health Therapeutic counselling Brief intervention Nursing and withdrawal support Nurse practitioners (withdrawal and prescribing) Peer support Referrals to specialist services (e.g. Addiction Medicine) Referrals to other health & community services Support to access pharmacotherapy Education and training programs Easily accessible Other drugs, n.e.c. 5% Amphetamines 3% Clients can access our service regardless of age or postcode Self-referrals are accepted via phone or website GPs and health professionals can refer via Medical Director/Best Practice, phone or website No Medicare card, Mental Health Treatment Plan or Chronic Disease Management Plan is needed Codeine 24% Opioid analgesics, n.f.d. 35% 1800 931 101 Benzodiazepines 33% 3

Outcomes 0.60 Average Number of Self-Reported Overdoses Not answered 0.55 7% Abstinence 19% 0.50 No change but reduced risk 16% 0.40 0.30 0.20 Reduction 29% 0.10 0.12 No Change 29% 0.00 Three Months prior to MSRS DURING Episode of Care Average Number of Self-reported ED/Hospital/Ambulance Presentations Kate 0.70 0.60 0.50 0.40 0.30 0.20 0.67 0.22 51yo Fractured wrist approx. 3 years ago GP prescribed Endone and made a referral to specialist clinic Engaged with MSRS Has seen a counsellor, nurse and engaged with peer support Referred to physiotherapist and dietician 0.10 0.00 Three Months PRIOR to MSRS DURING Episode of Care Margot George 60yo Referred by emergency services Misuse of opioids and Valium to manage physical health and anxiety Six ED presentations in 12 months Engaged with MSRS Has seen a counsellor, and nurse Referred to allied health including physiotherapy, occupational therapy and podiatry Referred to mental health nurse Collaboration with family in assessment, treatment and planning 53yo Procedure approx. six years ago: Post-op Endone GP prescribed Panadeine, and Panadeine Extra (320mg) Developed alcohol dependence Client tried to stop but had withdrawal symptoms Called MSRS after hearing about the service on the radio prior to 1 st Feb I don t know what I would have done if I didn t hear the radio that day Working with the nurse on a reduction plan 4

Sean 81yo Stomach pain approx. 1 year ago GP prescribed high doses of pain killers Procedure resolved pain but Sean continued to take over the counter codeine Sean tried to withdraw from medications but had the shakes and couldn t stop using Called the MSRS for help after finding the website Working with the nurse on a reduction plan How do I refer to MSRS? Questions? Clients can self-refer or be referred by a GP or health professional Refer via email, telephone or online (website) Contact us for more information 1800 931 101 msrs.intake@accesshc.org.au Julius Ting Project Co-Ordinator Julius.ting@accesshc.org.au Dr. Tamsin Short Senior Manager of Mental Health & AOD Tamsin.short@accesshc.org.au 5